Electrostatic potentials of camptothecin and its analogues

被引:0
|
作者
Jianyong Lei
Yun Chen
Xuejun Feng
Jian Jin
Jiande Gu
机构
[1] Jiangnan University,School of Medicine and Pharmaceutics
[2] Changzhou University,School of Petrochemical Engineering
[3] CAS,Drug Design and Discovery Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences
来源
关键词
Electrostatic potentials; Camptothecin; π–π Interaction;
D O I
暂无
中图分类号
学科分类号
摘要
In order to understand the influences of the modification of E-ring on the main frame of camptothecin (CPT), studies of the E-ring modification resulted changes in the stability and the electrostatic potential around the main frame of CPT were performed by the density functional theory. The results of present study indicate that the stability of the close-ring lactone form of CPT and homocamptothecin (hCPT) is similar to their open-ring hydroxylate forms, especially when in aqueous solutions. As an E-ring-modified CPT analogue, hCPT has essentially the same electrostatic potential (ESP) as CPT around the main frame (from A- to D-ring). However, the electrostatic potentials of the open-ring compounds are more negative around the main frame than that of CPT. The changes in the ESP of the CPT derivatives are found to be correlated with the corresponding dipole moments. Since electrostatic potential could influence the π–π stacking pattern between CPT (and its analogues) and the DNA bases, present study suggests that this π–π interaction of the open-ring forms of CPT and hCPT might be different from that of the close-ring lactone form. The information revealed in this study sheds light on the developments of new CPT-type antitumor drugs.
引用
收藏
相关论文
共 50 条
  • [1] Electrostatic potentials of camptothecin and its analogues
    Lei, Jianyong
    Chen, Yun
    Feng, Xuejun
    Jin, Jian
    Gu, Jiande
    THEORETICAL CHEMISTRY ACCOUNTS, 2014, 133 (10) : 1 - 6
  • [2] Camptothecin and its analogues: a review on their chemotherapeutic potential
    Sriram, D
    Yogeeswari, P
    Thirumurugan, R
    Bal, TR
    NATURAL PRODUCT RESEARCH, 2005, 19 (04) : 393 - 412
  • [3] Alternative administration of camptothecin analogues
    Verschraegen, CF
    Jaeckle, K
    Giovanella, B
    Knight, V
    Gilbert, BE
    CAMPTOTHECINS: UNFOLDING THEIR ANTICANCER POTENTIAL, 2000, 922 : 237 - 246
  • [4] Total Synthesis, Mechanism of Action, and Antitumor Efficacy of Camptothecin and Some of its Analogues
    Bacherikov, Valeriy A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (20) : 3438 - 3465
  • [5] A New Approach to Determine Camptothecin and Its Analogues Affinity to Human Serum Albumin
    Marszall, Michal Piotr
    Bucinski, Adam
    Kruszewski, Stefan
    Ziomkowska, Blanka
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (03) : 1142 - 1146
  • [6] The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues-A Status Report
    Strzelecka, Katarzyna
    Piotrowska, Urszula
    Sobczak, Marcin
    Oledzka, Ewa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [7] Phytochemical Analysis of Nothapodytes tomentosa and Distribution and Content of Camptothecin and its Analogues in Four Plants
    Li, Junheng
    Chen, Yin
    Wu, Lei
    Tuo, Xiaotao
    Wang, Li
    Zhou, Guanglian
    Huang, Sheng-Xiong
    Xiong, Wei
    Huang, Jian-Ping
    PLANTA MEDICA, 2023, 89 (13) : 1250 - 1258
  • [8] Subcellular localization of the camptothecin analogues, topotecan and gimatecan
    Croce, AC
    Bottiroli, G
    Supino, R
    Favini, E
    Zuco, V
    Zunino, F
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (06) : 1035 - 1045
  • [9] Anti-HSV activity of camptothecin analogues
    Liu, Ying-Qian
    Liu, Zhen-Ling
    Tian, Xuan
    Yang, Liu
    NATURAL PRODUCT RESEARCH, 2010, 24 (06) : 509 - 514
  • [10] Synthesis and in vitro cytotoxicity of hexacyclic camptothecin analogues
    Jew, SS
    Kim, HJ
    Kim, MG
    Roh, EE
    Hong, CI
    Kim, JK
    Lee, JH
    Lee, H
    Park, HG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (22) : 3203 - 3206